ETEC strains that express F4 (also known as K88) and F18 fimbriae—hair-like appendages the bacteria use to latch onto the gut lining—are the leading bacterial cause of diarrhea in newborn and weaned piglets. Post-weaning diarrhea, the signature illness of F18 strains, causes significant weight loss, high morbidity, and mortality, translating into substantial economic losses for the swine industry through reduced growth rates and rising veterinary costs. F18 strains are also linked to edema disease, a devastating condition caused by Shiga-like toxins that can kill apparently healthy, fast-growing piglets within hours. Traditional control measures, including zinc supplementation, antibiotics, probiotics, and prebiotics, are increasingly undermined by the spread of antimicrobial resistance, a problem driven in large part by the routine overuse of antibiotics in livestock feed, particularly in the United States. That growing resistance crisis, the researchers argue, makes it urgent to understand exactly how these pathogens evolve their virulence and how they interact with the host intestine.

The new study, led by Dongqi Liu and Arun K. Bhunia at Purdue University along with colleagues at several collaborating institutions, focused on three clinical F18 ETEC strains—designated 3EC1, 27EC1, and 3247EC—originally isolated from rectal swabs of pigs on swine farms. The team compared these against a porcine F4 strain, the human reference ETEC strain H10407, and the historical F18 reference strain E. coli Nysø, which serves as a stand-in for ancestral F18 traits. All three F18 isolates were confirmed as lactose-fermenting, beta-hemolytic bacteria capable of bursting red blood cells, and PCR testing verified the presence of the fedA gene—a 506-base-pair genetic marker encoding the structural backbone of F18 fimbriae that is strongly correlated with post-weaning diarrhea and edema disease. Control organisms, including an F4 strain, an F5 (K99) strain, and even Listeria monocytogenes, showed no trace of the gene.

Whole-genome sequencing, performed on an Illumina NextSeq 550 platform with reads assembled and annotated through bioinformatic pipelines including RAST, GTDB-Tk, and the Center for Genomic Epidemiology’s typing services, revealed striking heterogeneity among the F18 strains. Although all three belong to the same fimbrial pathotype, they differ substantially in their fimbrial loci, flagellin genes, lipopolysaccharide biosynthesis genes, and antimicrobial resistance determinants. Phylogenetic analysis based on 120 conserved proteins and whole-genome distance measures placed two of the isolates, 27EC1 and 3247EC, in a clade together with the porcine F4 strain, while 3EC1 clustered instead with the human strain H10407 and the ancestral Nysø strain—a branching pattern suggesting that F18 strains circulating in the field are not a single lineage but a collection of independently evolving populations acquiring virulence machinery from different sources.

The toxin profiles added another layer of concern. Strain 3EC1 uniquely carried stx2e, the Shiga-like toxin gene responsible for edema disease, meaning this isolate combines the colonizing power of an F18 strain with the lethal toxin arsenal of an edema disease pathogen. In addition, 3EC1 and 3247EC tested positive for non-classical variants of EAST1, an enterotoxin associated with diarrheal illness. Every F18 isolate encoded hlyE, a hemolysin gene consistent with their observed beta-hemolytic behavior on blood agar. Taken together, these findings indicate that modern F18 strains are assembling increasingly potent combinations of adhesins, toxins, and membrane-damaging factors—features that likely enhance their ability to colonize and damage the juvenile gut.

The antibiotic resistance picture was equally sobering. Strain 3247EC harbored the largest resistance repertoire the team detected, carrying 28 separate resistance genes, and all three F18 isolates demonstrated phenotypic resistance to multiple antibiotic classes. The researchers confirmed these patterns in the laboratory using broth microdilution assays to determine minimum inhibitory concentrations and agar disk diffusion tests to measure zones of inhibition, following Clinical and Laboratory Standards Institute protocols. The convergence of strong adhesion capacity, Shiga-toxin carriage, and extensive multidrug resistance in a single group of strains, the authors write, underscores an active evolution in virulence and reinforces the public health importance of antimicrobial resistance surveillance in swine—since resistant bacteria and their mobile resistance genes do not respect the boundary between barn and human community.

Beyond the genomics, the study’s most innovative contribution is its cell-based model of intestinal maturation. In living pigs, susceptibility to ETEC is strongly age-dependent: F4 strains predominantly sicken neonates, while F18 strains attack weaned animals, a pattern thought to reflect changing expression of intestinal receptors as the gut develops. To reproduce this dynamic in the laboratory, the researchers grew two porcine intestinal epithelial cell lines—IPEC-1 and IPEC-J2—to confluence and then maintained them for different periods: six days post-confluence representing an “Early” stage, nine days for “Mid,” and sixteen days for “Late” maturity. As the monolayers aged, their morphology transformed visibly, from crisp epithelioid sheets with defined borders to complex, overlapping tissue with cytoplasmic granules and vacuoles, mimicking the differentiation of the intestinal lining in a growing animal.

When the team exposed these maturation-staged cell layers to the bacteria at a multiplicity of infection of ten and quantified attached bacteria after thirty minutes, a clear pattern emerged. IPEC-1 cells expressed significantly higher levels of FUT1 and FUT2—the fucosyltransferase genes that produce the carbohydrate receptors F18 fimbriae recognize—than IPEC-J2 cells, and correspondingly, most F18 isolates adhered roughly twice as strongly to IPEC-1. Strain 3EC1 showed a distinctive spike in adhesion at the mid-maturation stage, reaching levels approaching those of the F4 strain, while strains 27EC1 and 3247EC attached consistently across all maturity stages. The F4 strain and the human strain H10407 consistently outperformed all F18 isolates by an order of magnitude across every model. Notably, a parallel experiment using human Caco-2 cells confirmed that adhesion behavior was reproducible across species boundaries. The FUT1/FUT2-driven maturation model, the team concludes, faithfully recapitulates the age-dependent susceptibility seen in the field, solving a long-standing puzzle created by conflicting evidence about receptor levels in newborn versus weaned piglets.

The research also clarified the molecular logic of F18 binding. The F18 operon comprises five genes, fedA through fedF, with FedA forming the pilus structural backbone and FedE and FedF mediating receptor binding alongside FedA. Because FUT1 expression in pigs naturally rises around three weeks of age and persists into adulthood—precisely the window when F18 strains strike weaned animals—the alignment between receptor dynamics and disease timing now has a workable experimental model. That matters for intervention design: vaccines, probiotics, feed additives, or genetic selection strategies aimed at blocking F18 colonization can now be screened against cell layers whose receptor biology matches the vulnerable stage of a piglet’s life.

For an industry grappling with the loss of antibiotic tools and the pressure to reduce zinc oxide supplementation, the integrated platform described in this study offers a practical path forward. It allows researchers to dissect host-pathogen interactions at defined developmental stages, to track the acquisition of virulence and resistance genes as field strains evolve, and to test targeted countermeasures before they ever reach an animal. And for the broader public health community, the message is harder to ignore: in the guts of weaned pigs, E. coli is quietly assembling the toolkit of a formidable pathogen—adhesion, toxins, and multidrug resistance in a single package—and keeping watch on that evolution is no longer optional.

The crux of the research lies in the unique characteristics of biochar, a porous and chemically reactive carbon-rich material traditionally used for soil enhancement and carbon sequestration. The team exploited biochar’s inherent porosity and surface chemistry to immobilize lysozyme molecules, ensuring their stability and controlled release within the gastrointestinal tract of livestock. By simulating the gastric environment of young pigs, the researchers demonstrated that the biochar-lysozyme complex remains stable in acidic stomach conditions, crucially shielding the enzyme from premature degradation.

The experimental design focused on the selective release of lysozyme triggered by pH variations, a property central to the strategy’s success. The enzyme’s antimicrobial activity is preserved during passage through the highly acidic stomach, with a limited amount released at low pH. Once the complex reaches the more neutral pH environment of the intestine, lysozyme is gradually liberated, thereby maximizing its beneficial effects on gut health and reducing pathogen colonization. This pH-responsive mechanism highlights biochar’s potential as a smart carrier that can spatially target bioactive delivery in the digestive system.

Synthetic antibiotics have long been the cornerstone of livestock disease management, particularly during stressful developmental phases such as weaning. However, their overuse has significantly contributed to the rise of antimicrobial resistance (AMR), a formidable threat to global health. Functional feed additives like lysozyme emerge as promising alternatives, but their widespread adoption has been hampered by instability in the harsh acidic conditions of the stomach. The biochar-based system pioneers a viable solution to this challenge, enhancing lysozyme’s durability and potential as a substitute to traditional antibiotics.

The methodological approach implemented by the scientists is notable for its simplicity and environmental friendliness. Lysozyme attachment to biochar particles was achieved through a mild, aqueous-based process, avoiding harsh chemicals or complex synthesis routes. The two types of biochar examined—derived respectively from chestnut shells and vine pruning wastes—both exhibited excellent binding capacity for lysozyme, underscoring the versatility of this waste-valorization pathway. This green chemistry approach aligns with the growing demand for sustainable and circular bioeconomy initiatives.

Advanced characterization techniques including high-resolution imaging and spectroscopy played a pivotal role in confirming the uniform distribution of lysozyme across the biochar surfaces. Unlike aggregated enzyme deposits, this homogeneous dispersion enhances the system’s stability and controlled release profile, ultimately improving bioavailability. These analyses provided crucial insights into the molecular interactions between biochar and lysozyme, deepening the understanding of how surface chemistry and porosity influence carrier performance.

Beyond the immediate implications for animal feed, this research also opens exciting avenues for broader applications in the fields of nutrition and pharmaceuticals. The concept of using biochar as a tailored delivery platform could be extended to humans, where protecting sensitive bioactives from gastric degradation is a persistent challenge. By harnessing the intrinsic structural and chemical features of biochar, future formulations could achieve targeted release of therapeutic agents, enhancing efficacy and reducing side effects.

Environmental considerations further amplify the significance of this innovation. Agricultural wastes such as chestnut shells and vine prunings are often discarded or combusted, contributing to pollution and greenhouse gas emissions. Transforming these residues into high-value biochar not only mitigates waste disposal problems but also generates multifunctional products that support sustainable livestock production. Additionally, biochar’s known benefits for soil amendment and nutrient retention may yield synergetic effects when integrated into agricultural cycles.

This research reflects a growing trend in material science and agronomy to fuse waste valorization with advanced functional design. By bridging disciplines, the study demonstrates how biochar—once considered a low-grade byproduct—can be engineered into smart materials tailored for complex biological environments. The strategy aligns well with global sustainability goals, offering a compelling example of how innovation can emerge from circular resource management principles.

The pH-responsive release mechanism remains a cornerstone discovery, offering a controlled, site-specific delivery that has long eluded conventional feed additives. The protective effect of biochar against enzymatic degradation in acidic settings combined with enhanced release at intestinal pH levels optimizes enzyme activity timing. This nuanced control is likely to translate into improved gut microbiota balance and immune function in livestock, with downstream effects on animal growth and productivity.

While the study concentrated on piglet models, implications extend across species and agricultural systems. The customizable nature of biochar production parameters allows tailoring physical and chemical properties to specific applications or animal species. Moreover, integrating this technology with other bioactive compounds could further diversify the functional feed additive landscape, fostering multifunctional solutions to disease prevention, nutrient delivery, and animal welfare.

Importantly, the transition away from antibiotics is not merely a scientific imperative but a socioeconomic priority, given the economic and public health costs associated with AMR. Innovations like the biochar-lysozyme delivery platform can contribute to safer, more resilient livestock production systems. They also resonate with consumer demands for antibiotic-free animal products, potentially reshaping market dynamics and regulatory frameworks.

In summary, this pioneering study transforms agricultural waste into a smart, sustainable vehicle for antimicrobial enzyme delivery, encapsulating a holistic approach to modern challenges in livestock health. By integrating material science, environmental stewardship, and animal nutrition, it provides a blueprint for innovation with both immediate and far-reaching impacts. The broader adoption of such biochar-based technologies promises to herald a new era in agricultural sustainability and bioactive delivery science.

Subject of Research: Experimental study on biochar-based delivery systems for antimicrobial compounds in livestock feed.

Article Title: Smart waste-derived materials for feed application: chestnut shells and vine pruning biochar

News Publication Date: 3-Feb-2026

Web References:
Biochar Journal
DOI Link

References:
Guagliano, M., Reggi, S., Dell’Anno, M. et al. Smart waste-derived materials for feed application: chestnut shells and vine pruning biochar. Biochar 8, 39 (2026).

Image Credits: Marianna Guagliano, Serena Reggi, Matteo Dell’Anno, Silvia Mostoni, Filippo Ottani, Marco Puglia, Giovanni Dotelli, Roberto Scotti, Simone Pedrazzi, Luciana Rossi, Cinzia Cristiani & Elisabetta Finocchio

Keywords: biochar, agricultural waste, lysozyme delivery, antimicrobial resistance, livestock feed, sustainable farming, pH-responsive release, enzyme stabilization, waste valorization, gut health, circular bioeconomy